LON:NIPT - Premaitha Health Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseGBX 8.90
Today's RangeGBX 8.70 - GBX 9.09
52-Week RangeGBX 4.05 - GBX 12.50
Volume559,761 shs
Average Volume395,406 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Premaitha Health PLC, a molecular diagnostic company, develops tests for non-invasive prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal screening test for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome. The IONA test is a diagnostic system that enables clinical laboratory customers to perform the test in their own facilities. The company is headquartered in Manchester, the United Kingdom.

Receive NIPT News and Ratings via Email

Sign-up to receive the latest news and ratings for NIPT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Laboratories & Research



Sales & Book Value

Annual SalesN/A



Next Earnings DateN/A
OptionableNot Optionable

Premaitha Health (LON:NIPT) Frequently Asked Questions

What is Premaitha Health's stock symbol?

Premaitha Health trades on the London Stock Exchange (LON) under the ticker symbol "NIPT."

How were Premaitha Health's earnings last quarter?

Premaitha Health PLC (LON:NIPT) released its quarterly earnings results on Friday, December, 29th. The company reported ($2.00) EPS for the quarter. The firm earned $2.71 million during the quarter. View Premaitha Health's Earnings History.

Has Premaitha Health been receiving favorable news coverage?

Media headlines about NIPT stock have trended somewhat positive this week, InfoTrie Sentiment reports. The research firm scores the sentiment of news coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Premaitha Health earned a coverage optimism score of 1.7 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the next several days.

Who are some of Premaitha Health's key competitors?

Some companies that are related to Premaitha Health include VolitionRX (VNRX), Spectral Medical (EDT), ANGLE (AGL), DiaSorin (DIA), Polarityte (COOL) and Proteome Sciences (PRM).

What other stocks do shareholders of Premaitha Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Premaitha Health investors own include Plethora Solutions (PLE), Vedanta Resources (VED), Mitie Group (MTO), Sirius Minerals (SXX), Scancell (SCLP), Rose Petroleum (ROSE), Royal Dutch Shell (RDSB), Aviva (AV), Lloyds Banking Group (LLOY) and Sareum (SAR).

Who are Premaitha Health's key executives?

Premaitha Health's management team includes the folowing people:
  • Dr. Stephen Little, Exec. Vice Chairman (Age 61)
  • Mr. Barry Hextall, CFO, Sec. & Exec. Director
  • Mr. Peter Collins, Chief Bus. Officer & Exec. Director (Age 59)
  • Mr. Lyn Fafydd Rees, CEO & Director (Age 45)
  • Dr. Chia-Han Chan, Chief Scientific Officer & Director (Age 42)

How do I buy shares of Premaitha Health?

Shares of NIPT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What is Premaitha Health's official website?

The official website for Premaitha Health is http://www.premaitha.com/.

How can I contact Premaitha Health?

Premaitha Health's mailing address is Rutherford House, 40 Pencroft Way, MANCHESTER, M15 6SZ, United Kingdom. The company can be reached via phone at +44-161-6676865.

MarketBeat Community Rating for Premaitha Health (LON NIPT)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  214 (Vote Outperform)
Underperform Votes:  241 (Vote Underperform)
Total Votes:  455
MarketBeat's community ratings are surveys of what our community members think about Premaitha Health and other stocks. Vote "Outperform" if you believe NIPT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NIPT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 2/23/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel